FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Cannabinoid and cannabinoid related receptors in fibroblasts...
Frontiers in veterinary science2025; 12; 1723160; doi: 10.3389/fvets.2025.1723160

Cannabinoid and cannabinoid related receptors in fibroblasts, inflammatory and endothelial cells of the equine hoof with and without laminitis: novel pharmacological target.

Abstract: Evidence suggests that the endocannabinoid system (ECS) is crucial for regulating inflammation, cell proliferation and pain. The ECS is composed of cannabinoid receptors such as type 1 (CBR1), type 2 (CBR2) and GPR55, endocannabinoids and enzymes. Proteins of ECS have previously been localized in the epidermal cells of the horse hooves. Given the physio-pathological role and cellular distribution of the ECS across species, the authors hypothesized that cannabinoid receptors are expressed within the inflammatory cells, fibroblasts and endothelial cells of the equine hoof laminae, going beyond the epidermal cells. Unassigned: To preliminary analyze the gene expression of Cn1r, Cn2r and GPR55 in the hoof laminae and test the specificity of the antibody against GPR55. To characterize the distribution and expression of CBRs in the inflammatory cells and fibroblasts of the laminar junction of equine healthy hooves and with laminitis. Unassigned: Animals were divided into 3 groups: healthy, acute laminitis and chronic laminitis. A total of 18 samples were collected and processed from the front limb of animals slaughtered for consumption or euthanized (6 control animals, 4 acute laminitis, 8 chronic laminitis). Unassigned: Analysis of CBR1, CBR2 and GPR55 protein expression was made by fluorescence microscopy with co-localization with antibodies against the macrophages marker IBA1, the T cell marker CD3, the neutrophils marker calprotectin (MAC387), the fibroblasts marker vimentin (Clove V9) and the nerve fibers marker Substance P. Preliminary analysis was performed to evaluate gene expression (, , and ) using real-time PCR and to verify the specificity of the primary antibody (Gpr55) with Western Blotting (WB). Unassigned: The resident pool of inflammatory cells in the normal laminae and the inflammatory infiltrate cells of the affected equine laminae showed protein expression of CB2R and GPR55; no CB1R staining was seen at the inflammatory cells. Equine dermal fibroblast and endothelial cells exhibited protein expressions of CB1R, CBR2 and GPR55. Substance P positive nerve fibers were positive for CB1R. Unassigned: Cannabinoid receptors are expressed in different immune cell types of the hoof laminae, pointing to the role of the ECS in modulating inflammatory outburst, tissue degeneration and pain. Our results serve as a foundation for the development of new veterinary pharmacotherapies that target the ECS during laminitis.
Copyright © 2025 Zamith Cunha, Gobbo, Morini, Salamanca, Zanoni, Bernardini, Gramenzi and Chiocchetti.
Get Full Text
Publication Date: 2025-11-28 PubMed ID: 41394912PubMed Central: PMC12699270DOI: 10.3389/fvets.2025.1723160Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates the presence and distribution of cannabinoid receptors in various cell types of the equine hoof, both healthy and affected by laminitis, to explore their potential as targets for new treatments.
  • The research focuses on cannabinoid receptors CB1R, CB2R, and GPR55 in inflammatory cells, fibroblasts, and endothelial cells within the hoof’s laminar tissue.

Introduction and Background

  • The endocannabinoid system (ECS) regulates inflammation, cell growth, and pain and includes cannabinoid receptors CB1R, CB2R, and GPR55, along with endogenous cannabinoids and enzymes.
  • Previous studies localized ECS proteins mainly in epidermal cells of horse hooves, but their presence in other cell types within hoof tissues had not been well characterized.
  • Given that laminitis involves inflammation and tissue degeneration in the hoof, understanding cannabinoid receptor expression could highlight novel pharmacological targets.

Objectives

  • Preliminarily analyze gene expression of the cannabinoid receptors (CB1R, CB2R, GPR55) in the laminar tissue of equine hooves using real-time PCR.
  • Test the specificity of antibodies targeting GPR55 via Western Blotting.
  • Characterize and map the protein expression of the three cannabinoid receptors in inflammatory cells, fibroblasts, and endothelial cells in both healthy and laminitic hooves using fluorescence microscopy.

Methods

  • Sample Collection:
    • 18 total samples from the front limbs of horses divided into groups: 6 healthy controls, 4 with acute laminitis, and 8 with chronic laminitis.
    • Samples obtained post-mortem from slaughtered or euthanized animals.
  • Immunofluorescence:
    • Used antibodies to detect CB1R, CB2R, and GPR55 protein expression.
    • Co-staining was performed with markers:
      • IBA1 for macrophages
      • CD3 for T cells
      • Calprotectin (MAC387) for neutrophils
      • Vimentin (Clove V9) for fibroblasts
      • Substance P for nerve fibers
  • Gene expression analysis employed real-time PCR for cannabinoid receptor genes.
  • Western Blotting confirmed the specificity of GPR55 antibodies.

Key Findings

  • Inflammatory Cells:
    • Macrophages, T cells, and neutrophils within the laminae expressed CB2R and GPR55.
    • No CB1R expression was detected in inflammatory cells.
  • Fibroblasts and Endothelial Cells:
    • Both expressed CB1R, CB2R, and GPR55 proteins.
  • Nerve Fibers:
    • Substance P-positive nerve fibers were positive for CB1R, which may relate to pain signaling pathways.

Interpretation and Significance

  • The presence of CB2R and GPR55 in immune cells implicates cannabinoid receptors in modulating inflammatory responses within the hoof, important for laminitis pathology.
  • Expression of all three receptors (CB1R, CB2R, GPR55) in fibroblasts and endothelial cells suggests the ECS could influence tissue remodeling and vascular function during laminitis.
  • The localization of CB1R in nerve fibers linked to pain transmission highlights the ECS’s potential role in managing laminitis-associated pain.
  • These findings establish a biological basis for developing therapies targeting cannabinoid receptors to control inflammation, reduce tissue damage, and alleviate pain in equine laminitis.

Conclusion

  • This research identifies cannabinoid receptors in diverse cell types related to inflammation and structural changes in both healthy and laminitic equine hooves, extending knowledge beyond previous epidermal studies.
  • The ECS represents a promising pharmacological target that could lead to innovative veterinary treatments for laminitis by modulating inflammation, tissue degeneration, and pain.

Cite This Article

APA
Zamith Cunha R, Gobbo F, Morini M, Salamanca G, Zanoni A, Bernardini C, Gramenzi A, Chiocchetti R. (2025). Cannabinoid and cannabinoid related receptors in fibroblasts, inflammatory and endothelial cells of the equine hoof with and without laminitis: novel pharmacological target. Front Vet Sci, 12, 1723160. https://doi.org/10.3389/fvets.2025.1723160

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 12
Pages: 1723160
PII: 1723160

Researcher Affiliations

Zamith Cunha, Rodrigo
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
  • Department of Veterinary Medicine, University of Teramo, Teramo, Italy.
Gobbo, Francesca
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Morini, Maria
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Salamanca, Giulia
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
  • Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy.
Zanoni, Augusta
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Bernardini, Chiara
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Gramenzi, Alessandro
  • Department of Veterinary Medicine, University of Teramo, Teramo, Italy.
Chiocchetti, Roberto
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 72 references
  1. Pollitt CC. Equine laminitis.. Clin Tech Equine Pract (2004) 3:34–44.
    doi: 10.1053/j.ctep.2004.07.003google scholar: lookup
  2. McGowan C. The role of insulin in endocrinopathic laminitis.. J Equine Vet Sci (2008) 28:603–7.
    doi: 10.1016/j.jevs.2008.08.004google scholar: lookup
  3. Fontaine GL, Belknap JK, Allen D, Moore JN, Kroll DL. Expression of interleukin-1β in the digital laminae of horses in the prodromal stage of experimentally induced laminitis.. Am J Vet Res (2001) 62:714–20.
    doi: 10.2460/ajvr.2001.62.714pubmed: 11341391google scholar: lookup
  4. Colmer SF, Adams AA, Adam E, Miller R, Stefanovski D, Kulp JC. The effect of pre-dosing with metformin on the insulin response to oral sugar in insulin-dysregulated horses.. Equine Vet J (2024) 56:318–25.
    doi: 10.1111/evj.13979pubmed: 37545128google scholar: lookup
  5. Godman JD, Burns TA, Kelly CS, Watts MR, Leise BS, Schroeder EL. The effect of hypothermia on influx of leukocytes in the digital lamellae of horses with oligofructose-induced laminitis.. Vet Immunol Immunopathol (2016) 178:22–8.
    doi: 10.1016/j.vetimm.2016.05.013pubmed: 27496739google scholar: lookup
  6. Lunn DP, Hurley DJ. The role of leukocyte biology in laminitis.. Vet Immunol Immunopathol (2009) 129:158–60.
    doi: 10.1016/j.vetimm.2008.11.014pubmed: 19091425google scholar: lookup
  7. Leise B. The role of neutrophils in equine laminitis.. Cell Tissue Res (2018) 371:541–50.
    doi: 10.1007/s00441-018-2788-zpubmed: 29397426google scholar: lookup
  8. Black SJ, Lunn DP, Yin C, Hwang M, Lenz SD, Belknap JK. Leukocyte emigration in the early stages of laminitis.. Vet Immunol Immunopathol (2006) 109:161–6.
    doi: 10.1016/j.vetimm.2005.08.017pubmed: 16169600google scholar: lookup
  9. Aragona F, Rizzo M, Giudice E, Fazio F, Costa A, Di Bella B. Circadian oscillation of leukocyte subpopulations and inflammatory cytokines over a 24-H period in horses.. Vet Sci (2025) 12:386.
    doi: 10.3390/vetsci12040386pmc: PMC12031226pubmed: 40284888google scholar: lookup
  10. Kumar D, Sharma A, Taliyan R, Urmera MT, Herrera-Calderon O, Heinbockel T. Orchestration of the circadian clock and its association with Alzheimer’s disease: role of endocannabinoid signaling.. Ageing Res Rev (2022) 73:101533.
    doi: 10.1016/j.arr.2021.101533pmc: PMC8729113pubmed: 34844016google scholar: lookup
  11. Murillo-Rodríguez E, Budde H, Veras AB, Rocha NB, Telles-Correia D, Monteiro D. The endocannabinoid system may modulate sleep disorders in aging.. Curr Neuropharmacol (2020) 18:97–108.
    doi: 10.2174/1570159X17666190801155922pmc: PMC7324886pubmed: 31368874google scholar: lookup
  12. Sládek M, Houdek P, Sumová A. Circadian profiling reveals distinct regulation of endocannabinoid system in the rat plasma, liver and adrenal glands by light-dark and feeding cycles.. Biochim Biophys Acta Mol Cell Biol Lipids (2019) 1864:158533.
    doi: 10.1016/j.bbalip.2019.158533pubmed: 31676438google scholar: lookup
  13. Chiocchetti R, Rinnovati R, Tagliavia C, Stanzani A, Galiazzo G, Giancola F. Localisation of cannabinoid and cannabinoid-related receptors in the equine dorsal root ganglia.. Equine Vet J (2021) 53:549–57.
    doi: 10.1111/evj.13305pubmed: 32524649google scholar: lookup
  14. Galiazzo G, Tagliavia C, Giancola F, Rinnovati R, Sadeghinezhad J, Bombardi C. Localisation of cannabinoid and cannabinoid-related receptors in the horse ileum.. J Equine Vet Sci (2021) 104:103688.
    doi: 10.1016/j.jevs.2021.103688pubmed: 34416995google scholar: lookup
  15. Cunha RZ, Zannoni A, Salamanca G, De Silva M, Rinnovati R, Gramenzi A. Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint.. Front Vet Sci (2023) 10:5030.
    doi: 10.3389/fvets.2023.1045030pmc: PMC10020506pubmed: 36937015google scholar: lookup
  16. Cunha RZ, Semprini A, Salamanca G, Gobbo F, Morini M, Pickles KJ, et al. Expression of cannabinoid receptors in the trigeminal ganglion of the horse. Int J Mol Sci. (2023) 24:949. doi: 10.3390/ijms242115949,
    doi: 10.3390/ijms242115949pmc: PMC9866564pubmed: 36674466google scholar: lookup
  17. Zamith Cunha R, Gobbo F, Morini M, Zannoni A, Mainardi C, D’arpe L, et al. Distribution of endocannabinoid system receptors in the equine hoof: dysregulation as a potential therapeutic target for laminitis. Histochem Cell Biol. (2025) 163:71. doi: 10.1007/s00418-025-02397-y,
    doi: 10.1007/s00418-025-02397-ypubmed: 40593311google scholar: lookup
  18. Di Salvo A, Chiaradia E, Sforna M, della Rocca G. Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review. Vet Res Commun. (2024) 48:2915–41. doi: 10.1007/s11259-024-10509-7,
    doi: 10.1007/s11259-024-10509-7pmc: PMC11442603pubmed: 39162768google scholar: lookup
  19. Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The endocannabinoid system: a potential target for the treatment of various diseases. Int J Mol Sci. (2021) 22:9472. doi: 10.3390/ijms22179472,
    doi: 10.3390/ijms22179472pmc: PMC8430969pubmed: 34502379google scholar: lookup
  20. Cohen L, Jones T, Guay K, Smith WB, Nichols J, Elwonger F. 62 evaluation of oral supplementation of cannabidiol (CBD) in horses. J Equine Vet Sci. (2021) 100:103525. doi: 10.1016/j.jevs.2021.103525
    doi: 10.1016/j.jevs.2021.103525google scholar: lookup
  21. Eichler F, Poźniak B, Machnik M, Schenk I, Wingender A, Baudisch N, et al. Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses. Front Vet Sci. (2023) 10:551. doi: 10.3389/fvets.2023.1234551,
    doi: 10.3389/fvets.2023.1234551pmc: PMC10445762pubmed: 37621871google scholar: lookup
  22. Aragona F, Tabbì M, Gugliandolo E, Giannetto C, D’Angelo F, Fazio F, et al. Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis. Front Vet Sci. (2024) 11:473. doi: 10.3389/fvets.2024.1496473,
    doi: 10.3389/fvets.2024.1496473pmc: PMC11668182pubmed: 39720409google scholar: lookup
  23. Cunha RZ, Felisardo LL, Salamanca G, Marchioni GG, Neto OI, Chiocchetti R. The use of cannabidiol as a novel treatment for oral stereotypic behaviour (crib-biting) in a horse. Vet Anim Sci. (2023) 19:100289. doi: 10.1016/j.vas.2023.100289,
    doi: 10.1016/j.vas.2023.100289pmc: PMC9941357pubmed: 36824298google scholar: lookup
  24. Ellis KL, Contino EK. Treatment using cannabidiol in a horse with mechanical allodynia. Equine Vet Educ. (2021) 33:168. doi: 10.1111/eve.13168
    doi: 10.1111/eve.13168google scholar: lookup
  25. Turner S, Knych HK, Adams AA. The effects of cannabidiol on immune function and health parameters in senior horses. Vet Immunol Immunopathol. (2023) 257:110549. doi: 10.1016/j.vetimm.2023.110549,
    doi: 10.1016/j.vetimm.2023.110549pubmed: 36682327google scholar: lookup
  26. Van Eps AW. Acute laminitis: medical and supportive therapy. Vet Clin North Am Equine Pract. (2010) 26:103–14. doi: 10.1016/j.cveq.2009.12.011,
    doi: 10.1016/j.cveq.2009.12.011pubmed: 20381739google scholar: lookup
  27. Parks A, O’Grady SE. Chronic laminitis: current treatment strategies. Vet Clin North Am Equine Pract. (2003) 19:393–416. doi: 10.1016/S0749-0739(03)00019-1
    doi: 10.1016/S0749-0739(03)00019-1pubmed: 14575166google scholar: lookup
  28. Kawasako K, Higashi T, Nakaji Y, Komine M, Hirayama K, Matsuda K, et al. Histologic evaluation of the diversity of epidermal laminae in hooves of horses without clinical signs of laminitis. Am J Vet Res. (2009) 70:186–93. doi: 10.2460/ajvr.70.2.186,
    doi: 10.2460/ajvr.70.2.186pubmed: 19231949google scholar: lookup
  29. Pollitt CC. Basement membrane pathology: a feature of acute equine laminitis. Equine Vet J. (1996) 28:38–46. doi: 10.1111/j.2042-3306.1996.tb01588.x,
    doi: 10.1111/j.2042-3306.1996.tb01588.xpubmed: 8565952google scholar: lookup
  30. Douglas JE, Thomason JJ. Shape, orientation and spacing of the primary epidermal laminae in the hooves of neonatal and adult horses (). Cells Tissues Organs. (2000) 166:304–18. doi: 10.1159/000016744n
    doi: 10.1159/000016744pubmed: 10765026google scholar: lookup
  31. Zannoni A, Bombardi C, Dondi F, Morini M, Forni M, Chiocchetti R, et al. Proteinase-activated receptor 2 expression in the intestinal tract of the horse. Res Vet Sci. (2014) 96:464–71. doi: 10.1016/j.rvsc.2014.03.006,
    doi: 10.1016/j.rvsc.2014.03.006pubmed: 24656343google scholar: lookup
  32. Galiazzo G, Giancola F, Stanzani A, Fracassi F, Bernardini C, Forni M, et al. Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract. Histochem Cell Biol. (2018) 150:187–205. doi: 10.1007/s00418-018-1684-7,
    doi: 10.1007/s00418-018-1684-7pubmed: 29882158google scholar: lookup
  33. Chiocchetti R, Galiazzo G, Tagliavia C, Stanzani A, Giancola F, Menchetti M, et al. Cellular distribution of canonical and putative cannabinoid receptors in canine cervical dorsal root ganglia. Front Vet Sci. (2019) 6:313. doi: 10.3389/fvets.2019.00313,
    doi: 10.3389/fvets.2019.00313pmc: PMC6761858pubmed: 31608295google scholar: lookup
  34. Kupczyk P, Rykala M, Serek P, Pawlak A, Slowikowski B, Holysz M, et al. The cannabinoid receptors system in horses: tissue distribution and cellular identification in skin. J Vet Intern Med. (2022) 36:1508–24. doi: 10.1111/jvim.16467,
    doi: 10.1111/jvim.16467pmc: PMC9308437pubmed: 35801813google scholar: lookup
  35. Bombardi C, Salamanca G, Tagliavia C, Grandis A, Zamith Cunha R, Gramenzi A, et al. Cannabinoid receptors in the horse lateral nucleus of the amygdala: a potential target for ameliorating pain perception, stress and anxiety in horses. Int J Mol Sci. (2025) 26:7613. doi: 10.3390/ijms26157613,
    doi: 10.3390/ijms26157613pmc: PMC12347058pubmed: 40806746google scholar: lookup
  36. Chiocchetti R, Salamanca G, De Silva M, Gobbo F, Aspidi F, Cunha RZ, et al. Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis. Front Vet Sci. (2022) 9:132. doi: 10.3389/fvets.2022.987132,
    doi: 10.3389/fvets.2022.987132pmc: PMC9521433pubmed: 36187821google scholar: lookup
  37. Polidoro G, Galiazzo G, Giancola F, Papadimitriou S, Kouki M, Sabattini S, et al. Expression of cannabinoid and cannabinoid-related receptors in the oral mucosa of healthy cats and cats with chronic gingivostomatitis. J Feline Med Surg. (2021) 23:679–91. doi: 10.1177/1098612X20970510,
    doi: 10.1177/1098612X20970510pmc: PMC10812186pubmed: 33174485google scholar: lookup
  38. Galiazzo G, De Silva M, Giancola F, Rinnovati R, Peli A, Chiocchetti R. Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia. Equine Vet J. (2022) 54:788–98. doi: 10.1111/evj.13499,
    doi: 10.1111/evj.13499pmc: PMC9293124pubmed: 34418142google scholar: lookup
  39. Zamith Cunha R, Salamanca G, Mille F, Delprete C, Franciosi C, Piva G, et al. Endocannabinoid system receptors at the hip and stifle joints of middle-aged dogs: a novel target for the therapeutic use of extract in canine Arthropathies. Animals. (2023) 13:833. doi: 10.3390/ani13182833, n
    doi: 10.3390/ani13182833pmc: PMC10000061pubmed: 36899690google scholar: lookup
  40. Chiocchetti R, De Silva M, Aspidi F, Cunha RZ, Gobbo F, Tagliavia C, et al. Distribution of cannabinoid receptors in keratinocytes of healthy dogs and dogs with atopic dermatitis. Front Vet Sci. (2022) 9:896. doi: 10.3389/fvets.2022.915896,
    doi: 10.3389/fvets.2022.915896pmc: PMC9305491pubmed: 35873682google scholar: lookup
  41. Keresztes G, Glávits R, Krenács L, Kurucz É, Andó I. An anti-CD3ϵ serum detects T lymphocytes in paraffin-embedded pathological tissues in many animal species. Immunol Lett. (1996) 50:167–72. doi: 10.1016/0165-2478(96)02534-5,
    doi: 10.1016/0165-2478(96)02534-5pubmed: 8803615google scholar: lookup
  42. Deeg CA, Reese S, Gerhards H, Wildner G, Kaspers B. The Uveitogenic potential of retinal S-antigen in horses. Invest Opthalmol Vis Sci. (2004) 45:2286–92. doi: 10.1167/iovs.03-1226,
    doi: 10.1167/iovs.03-1226pubmed: 15223807google scholar: lookup
  43. Russo D, Bombardi C, Castellani G, Chiocchetti R. Characterization of spinal ganglion neurons in horse (). A morphometric, neurochemical and tracing study. Neuroscience. (2011) 176:53–71. doi: 10.1016/j.neuroscience.2010.12.042, n
    doi: 10.1016/j.neuroscience.2010.12.042pubmed: 21193019google scholar: lookup
  44. Cerrato S, Ramió-Lluch L, Brazís P, Rabanal RM, Fondevila D, Puigdemont A. Development and characterization of an equine skin-equivalent model. Vet Dermatol. (2014) 25:e77: 475. doi: 10.1111/vde.12134,
    doi: 10.1111/vde.12134pubmed: 25041278google scholar: lookup
  45. Włodarczyk M, Sobolewska-Włodarczyk A, Cygankiewicz AI, Jacenik D, Krajewska WM, Stec-Michalska K, et al. G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn’s disease and ulcerative colitis. Scand J Gastroenterol. (2017) 52:711–5. doi: 10.1080/00365521.2017.1298834,
    doi: 10.1080/00365521.2017.1298834pubmed: 28272905google scholar: lookup
  46. Bohm A, Gaudet R, Sigler PB. Structural aspects of heterotrimeric G-protein signaling. Curr Opin Biotechnol. (1997) 8:480–7. doi: 10.1016/S0958-1669(97)80072-9,
    doi: 10.1016/S0958-1669(97)80072-9pubmed: 9265729google scholar: lookup
  47. Neer EJ. Heterotrimeric C proteins: organizers of transmembrane signals. Cell. (1995) 80:249–57. doi: 10.1016/0092-8674(95)90407-7,
    doi: 10.1016/0092-8674(95)90407-7pubmed: 7834744google scholar: lookup
  48. Alcantara KP, Malabanan JWT, Nalinratana N, Thitikornpong W, Rojsitthisak P, Rojsitthisak P. Cannabidiol-loaded solid lipid nanoparticles ameliorate the inhibition of Proinflammatory cytokines and free radicals in an in vitro inflammation-induced cell model. Int J Mol Sci. (2024) 25:4744. doi: 10.3390/ijms25094744,
    doi: 10.3390/ijms25094744pmc: PMC11083812pubmed: 38731964google scholar: lookup
  49. Yu CHJ, Rupasinghe HPV. Cannabidiol-based natural health products for companion animals: recent advances in the management of anxiety, pain, and inflammation. Res Vet Sci. (2021) 140:38–46. doi: 10.1016/j.rvsc.2021.08.001,
    doi: 10.1016/j.rvsc.2021.08.001pubmed: 34391060google scholar: lookup
  50. Faleiros RR, Nuovo GJ, Flechtner AD, Belknap JK. Presence of mononuclear cells in normal and affected laminae from the black walnut extract model of laminitis. Equine Vet J. (2011) 43:45–53. doi: 10.1111/j.2042-3306.2010.00121.x,
    doi: 10.1111/j.2042-3306.2010.00121.xpubmed: 21143633google scholar: lookup
  51. Yang G, Im H-J, Wang JH-C. Repetitive mechanical stretching modulates IL-1β induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts. Gene. (2005) 363:166–72. doi: 10.1016/j.gene.2005.08.006,
    doi: 10.1016/j.gene.2005.08.006pmc: PMC2901527pubmed: 16226404google scholar: lookup
  52. Sheats MK. A comparative review of equine SIRS, Sepsis, and neutrophils. Front Vet Sci. (2019) 6:69. doi: 10.3389/fvets.2019.00069,
    doi: 10.3389/fvets.2019.00069pmc: PMC6424004pubmed: 30931316google scholar: lookup
  53. Turner S, Barker VD, Adams AA. Effects of Cannabidiol on the in vitro lymphocyte pro-inflammatory cytokine production of senior horses. J Equine Vet Sci. (2021) 103:103668. doi: 10.1016/j.jevs.2021.103668,
    doi: 10.1016/j.jevs.2021.103668pubmed: 34281647google scholar: lookup
  54. Wang B, Kovalchuk A, Li D, Rodriguez-Juarez R, Ilnytskyy Y, Kovalchuk I, et al. In search of preventative strategies: novel high-CBD extracts modulate ACE2 expression in COVID-19 gateway tissues. Aging. (2020) 12:225. doi: 10.18632/aging.202225
    doi: 10.18632/aging.202225google scholar: lookup
  55. Lowin T, Apitz M, Anders S, Straub RH. Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner. Arthritis Res Ther. (2015) 17:321. doi: 10.1186/s13075-015-0845-5,
    doi: 10.1186/s13075-015-0845-5pmc: PMC4644337pubmed: 26567045google scholar: lookup
  56. Kyaw-Tanner M, Pollitt CC. Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. Equine Vet J. (2004) 36:221–5. doi: 10.2746/0425164044877242,
    doi: 10.2746/0425164044877242pubmed: 15147128google scholar: lookup
  57. Gęgotek A, Atalay S, Rogowska-Wrzesińska A, Skrzydlewska E. The effect of Cannabidiol on UV-induced changes in intracellular signaling of 3D-cultured skin keratinocytes. Int J Mol Sci. (2021) 22:1501. doi: 10.3390/ijms22031501,
    doi: 10.3390/ijms22031501pmc: PMC7867360pubmed: 33540902google scholar: lookup
  58. Kobayashi T, Hattori S, Shinkai H. Matrix Metalloproteinases-2 and -9 are secreted from human fibroblasts. Acta Derm Venereol. (2003) 83:105–7. doi: 10.1080/00015550310007436,
    doi: 10.1080/00015550310007436pubmed: 12735637google scholar: lookup
  59. Atalay S, Gęgotek A, Skrzydlewska E. Protective effects of Cannabidiol on the membrane proteome of UVB-irradiated keratinocytes. Antioxidants. (2021) 10:402. doi: 10.3390/antiox10030402,
    doi: 10.3390/antiox10030402pmc: PMC8001542pubmed: 33800305google scholar: lookup
  60. Mallat A, Teixeira-Clerc F, Deveaux V, Manin S, Lotersztajn S. The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings. Br J Pharmacol. (2011) 163:1432–40. doi: 10.1111/j.1476-5381.2011.01397.x,
    doi: 10.1111/j.1476-5381.2011.01397.xpmc: PMC3165953pubmed: 21457226google scholar: lookup
  61. Hurley DJ, Parks RJ, Reber AJ, Donovan DC, Okinaga T, Vandenplas ML, et al. Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract. Vet Immunol Immunopathol. (2006) 110:195–206. doi: 10.1016/j.vetimm.2005.09.015,
    doi: 10.1016/j.vetimm.2005.09.015pubmed: 16290066google scholar: lookup
  62. Menzies-Gow NJ, Wray H, Bailey SR, Harris PA, Elliott J. The effect of tumour necrosis factor-α and insulin on equine digital blood vessel function in vitro. Inflamm Res. (2014) 63:637–47. doi: 10.1007/s00011-014-0736-2,
    doi: 10.1007/s00011-014-0736-2pubmed: 24764104google scholar: lookup
  63. Xu X, Guo H, Jing Z, Yang L, Chen C, Peng L, et al. N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNF-α-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α. J Cardiovasc Pharmacol. (2016) 68:280–91. doi: 10.1097/FJC.0000000000000413,
    doi: 10.1097/FJC.0000000000000413pubmed: 27281236google scholar: lookup
  64. Gasperi V, Evangelista D, Chiurchiù V, Florenzano F, Savini I, Oddi S, et al. 2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors. Int J Biochem Cell Biol. (2014) 51:79–88. doi: 10.1016/j.biocel.2014.03.028,
    doi: 10.1016/j.biocel.2014.03.028pubmed: 24721209google scholar: lookup
  65. Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Batkai S, et al. N -arachidonoyl l-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proc Natl Acad Sci U S A. (2006) 103:2428–33. doi: 10.1073/pnas.0510676103,
    doi: 10.1073/pnas.0510676103pmc: PMC1413724pubmed: 16467152google scholar: lookup
  66. Henstridge CM, Balenga NAB, Kargl J, Andradas C, Brown AJ, Irving A, et al. Minireview: recent developments in the physiology and pathology of the Lysophosphatidylinositol-sensitive receptor GPR55. Mol Endocrinol. (2011) 25:1835–48. doi: 10.1210/me.2011-1197,
    doi: 10.1210/me.2011-1197pmc: PMC5417173pubmed: 21964594google scholar: lookup
  67. Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, et al. The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain. (2008) 139:225–36. doi: 10.1016/j.pain.2008.04.006,
    doi: 10.1016/j.pain.2008.04.006pubmed: 18502582google scholar: lookup
  68. Walsh SK, Hector EE, Andréasson A-C, Jönsson-Rylander A-C, Wainwright CL. GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired Adrenoceptor-mediated inotropic responses. PLoS One. (2014) 9:e108999. doi: 10.1371/journal.pone.0108999,
    doi: 10.1371/journal.pone.0108999pmc: PMC4183508pubmed: 25275556google scholar: lookup
  69. Tiyerili V, Zimmer S, Jung S, Wassmann K, Naehle CP, Lütjohann D, et al. CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function. Basic Res Cardiol. (2010) 105:465–77. doi: 10.1007/s00395-010-0090-7,
    doi: 10.1007/s00395-010-0090-7pubmed: 20361197google scholar: lookup
  70. Zurier RB, Burstein SH. Cannabinoids, inflammation, and fibrosis. FASEB J. (2016) 30:3682–9. doi: 10.1096/fj.201600646R,
    doi: 10.1096/fj.201600646Rpubmed: 27435265google scholar: lookup
  71. Liu X, Li L, Jiang J, Ge W, Huang Y, Jin Z, et al. Role of type I cannabinoid receptor in sensory neurons in Psoriasiform skin inflammation and pruritus. J Invest Dermatol. (2023) 143:e3: 812–21. doi: 10.1016/j.jid.2022.10.014,
    doi: 10.1016/j.jid.2022.10.014pubmed: 36410425google scholar: lookup
  72. Interlandi C, Tabbì M, Di Pietro S, D’Angelo F, Costa GL, Arfuso F, et al. Improved quality of life and pain relief in mature horses with osteoarthritis after oral transmucosal cannabidiol oil administration as part of an analgesic regimen. Front Vet Sci. (2024) 11:1396. doi: 10.3389/fvets.2024.1341396,
    doi: 10.3389/fvets.2024.1341396pmc: PMC10876772pubmed: 38379920google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,001 horse owners like you who receive our email updates on horse health and nutrition.